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SUMMARY : Forty-seven patients with digestive tract malignancy and some 
benign diseases (cholelithiasis, duodenal ulcer) disease were subject to this study to 
clarify the changes in immunologic state in terms of complements. It has been often 
reported that circulating immune complex (CIC) was detected in infections disease. 
But CIC is also able to be detected in malignant disease without infection. The blood 
level of CIC changes regularly in perioperative period at the time of surgical resec-
tion of malignancy. In fact, preoperative value returned to normal in absolute cura-
tive operation for gastric cancer. Meanwhile, it was. variable during 7 days after ope-
ration in either benign or malignant diseases of gastrointestinal tract. The reason is 
that early period of surgery tends to be affected by operation insult, induced 
catabolic metabolism, nutritional defect and infection. After surgery to the liver, the 
changes in CIC were characteristic and CRA was suppressed coutinuously. Comple-
ment. protein C3, which is the most important component in CRA reaction, is 
generated in the liver. Therefore, it is considered that blood level of CRA is easily 
affected when hepatic surgery is made.
       INTRODUCTION 
 Immunological depression of the host to 
surgical stress may be one of the most impor-
tant problem to improve the outcome of 
surgery. There are many studies on cellular 
immunity in association with operation, but it 
is very rare on CIC and CRA. Serum level of 
CIC is often measured in order to assess the 
curability of collagen diseases. And it also 
rises in infectious diseases. But its value may 
be utilized in assessment of severity of malig-
nant disease which is not complicated with 
collagen disease and has no infection. 
KL'SAKAWA7) proved high level of CIC in advanced 
cancer in 1983. While CRA was able to assay 
without radioisotope in 1980 by TAKATASI-11 ). 
He has proved that complement protein C3 was
the most important element in reaction of 
CRA. NISHIKAWA8) reported that C3 increased as 
developement of malignant disease in 1976. So, 
CRA may also change due to severity of cancer 
or surgical intervension. Then, it is of value to 
clarify the immune mechanism to know the 
changes in CIC and CRA in relation to surgery 
and advancing the cancer stages. The purpose 
of this study is to clarify their postoperative 
changes and clinical significances.
   MATERIAL AND METHOD 
 Forty-seven patients with gastrointestinal 
cancer, hepatoma and some benign diseases 
were eligible for this study. There were 24 men 
and 23 women. The mean age was 60.8 years, 
with a range of 26-79 years. CIC was measured 
by polyethylene glycol complement consumption
Fig. 1.
test. CRA was measured by AMnrro's method. 
Nutritional status was assesed by weight, 
arm circumference (AC), arm muscle circum-
ference (AMC ), triceps skinfold thickness 
(TSF) and rapid turnover protein which was 
retinol binding protein (RBP ), prealbumin (P 
A) and transferine (TF). The measurement of 
CIC was as follows. 
 Borate buffer, EDTA and PEG 6000 were 
mixed properly. It was kept at 4°C for 90 min, 
centrifuged at 1700 G for 10 min and washed 
by 2.5% PEG, followed by spun again at 1700 
G for 15 min at 4°C. The pellect was added by 
GVB2+ and NHS, incubated at 37°C for 30 min. 
It was maintained at 37°C for 60 min after the 
addition of EA, and was mixed with cold 
isotonic saline. The absorbance was measured 
at O.D. 450nm by spectrophotometry. The 
measurement of CRA was as follows. Precipi-
table immune complex produced by horseradish 
peroxidase and anti-PO rabbit IgG for an hour 
at 37°C was left overnight at 4°C, followed by 
wash out by ASA. PO-IC and sample sera 
incubated and centrifuged. After addition of 
ASA, it was incubated at 37°C, The reaction 
was discontinued by NaOH. The value of* absor-
bance at O.D. 450nm were regarded as the 
value of CRA. (Fig. 1)
          RESULT 
 The two patients with elevated CIC in 6 
benign diseases were complicated with infec-
tious diseases. Blood level of CIC in the
presence of malignant disease rose more than 
that in normal adult. But one with a large 
size hepatoma had minimal value of CIC. Its 
value in all early gastric cancers and colon 
cancers were almost within normal limit. (Fig. 
2)
                                               cancer 
Fig. 2. PEG-CC% of peripheral blood tended to 
       increase in malignancy. Benign disease 
      with infection had higher CIC value
 CRA values of stomach cancers increased in 
comparison with the control. (p<0.01) It was 
also statistically significant in colon and 
rectal cancers (p<0.05). But in hepatoma CRA 
levels were lowered when compared with those 
in stomach cancers. (p<0.05) In benign disease 
and pancreas cancers, there were no statistical 
significance. In hepatoma CIC levels were 
reduced, and it was characteristic in compari-
son with those in other gastrointestinal 
malignant diseases. (Fig. 3)
 CIC was measured periodically in six pati-
ents with benign diseases. There were 3 
cholelithiasis without jaundice, 2 duodenal ul-
cers and 1 ulcer of ileum. In 2 cases CIC was ele-
vated, while it returned to normal soon after 
operation. In 4 cases CIC varied with a vary-
ing variety until on day 14 after surgery. Such 
a tendency was remarkable from the 3rd to the 
10th day after surgery in 4 cases. (Fig. 5)
Fig. 3. The CRA value of gastrointestinal cance 
       r increased in comparison with control.
       But its value of hepatoma lower than 
       that of stomach cancer.
 It was disclosed that CRA changed according 
to the disease stage. in gastric cancers. The 
values in stage II diseases increased more than 
those of the control. (p<0.05) An increase in 
CRA in stage IV was evident and statistically 
significant. (p<0.05). The CRA levels increas-
ed in stage III . (p < 0.01) In early gastric 
cancers the CIC and CRA levels were almost 
normal and there was no difference from the 
control. (Fig. 4)
Fig. 5. Peripheral blood level of CIC was 
       measured periodically after operation 
       of benign diseases. It revealed variable 
      change from 3rd day 10th day.
 There were 5 cases whose CIC were not 
detected or less than 10%. Three were choleli-
thiasis, others were duodenal ulcers and early 
gastric cancer. Each case revealed variable 
changes from the 3rd to 10th day, but all 
recovered to preoperative level on the 14th day 
after surgery. (Fig. 6)
Fig. 6. There was 5 cases whose CIC level was 
       not detected or less than 10% in preoper-
       ative day. Each case had variable CIC 
      level from 3rd day to 10th day. All 
       cases were recovered to preoperative 
      level on 14th day.
Fig. 4. The CRA value of stage I gastric cancer 
       was unchanged. But its values of stage II 
       and IV increased comparatively.
 Postoperative changes of CIC in gastric 
cancer in relation to oncological curability 
were evaluated. Closed circle means absolute
curative resection cases, and open circle means 
noncurative resection cases. Preoperative CIC 
levels had increased except for 2 cases. It 
tended to be lowered until the 3rd day. All 
revealed variable changes from the 3rd to the 
10th day. It was reduced on the 14th day in 
absolute curative cases, and was statistically 
significant. (p<0.05) But there was a tendency 
toward an increase in patients with non-
curative resection. (Fig. 7)
Fig. 8. 5 hepatoma were studied. There were 2 
      right lobectomy, a left lobectomy and 2
       resection of Counaud's Segment. PEG-
      CC% of all were depressed until 7th day.
Fig. 7. These CIC values showed postoperative 
       change of gastric cancer in relation to 
       its curability. It was decreased on 14th
       day in absolute curative cases. Some
      case had higher CIC level on 14th day 
       than preoperative level in non-ctrative 
        resection cases.
 Five hepatocellular carcinomas were studied. 
Two showed a normal CIC and another had an 
elevated CIC in the perioperative state. Right 
lobectomy in 2 left lobectomy in 1, S2S3 resec-
tion in 1 and S7 S8 resection in 1 were performed. 
CIC levels in these patients who underwent 
hepatectomy for hepatoma were depressed 
until the 7th day. These increased markedly in 
3 cases on the 7th day or the 10th day. But 
they returned to the preoperative level on the 
14th day. The postoperative courses were 
different from those in benign or other malig-
nant diseases of the digestive tract. (Fig. 8) 
 Changes in CRA were evaluated in 5 cases. 
The CRA levels in all were continuously low 
for 14 days. (Fig. 9) 
 In patients with hepatectomy and gastrec-
tomy, the nutritional status was studied. 
 There is no statistical significance . in 
anthrophemetic measurement (Weight, AC, 
AMC, TSF) between the patients with resec-
Fig. 9. Complex release activity of complement 
       were studied in 5 hepatoma. CRA value 
       of all case wene continuously depressed 
      during 14 days after operation.
tions of the liver and the stomach. (Fig. 10)
Fig. 10
 Retinol-binding protein recovered on the 7th 
day in gastrectomy (p<0.05), but by partial 
resection of the liver it rose to normal on the 
14th day (p<0.01). (Fig. 11) 
 The postoperative levels of prealbumin 
showed no remarkable change for 14 days both 
the patients with the resection of the liver and
Fig. 11
the stomach. (Fig. 12) 
 The transferine level on the 3rd day was 
much more elevated than its level on the 1st 
day in gastrectomy. (p<0.05) No remarkable 
change was found for 14 days in patients with 
partial resection of the liver. (Fig. 13)
       DISCUSSION 
HARKISS and BRAUN1) reported a new assay for
the detection of CIC, the polyethylene glycol 
precipitation complement consumption assay 
(PEG-CC) in 1979. Since that time, the method 
of CIC detection has become common in the 
clinical use. However, a method according to 
Raji cell assay 2) is unavoidable with the use 
of isotope so that it is a great barrier to use 
in the laboratory. On the other hand, PEG-CC 
measurement require a spectrophotometric 
method. Therefore PEG-CC is available with
Fig. 12
Fig. 13
the detection of CIC. The CIC values measured 
by PEG-CC are not different from those 
obtained by Raji cell assay. There were a few 
reports with respect to the detection of CIC in 
malignant diseases 3 ). Each author reported 
that CIC increased according to the extension 
of cancer infiltration. Detected IC by PEG-CC 
did not show a special pattern in any malig-
nant and infectious disease. There are some 
trials to evaluate the changes in IC for 
specific tumor antigens, although it was not 
commonly employed and not standardized. 
PEG-CC was a kind of non-special IC. It was 
often detected in malignant diseases without 
infection. In fact, it was assumed that CIC 
was consistent with staging of a malignant 
disease. The changes in CIC also well reflects 
the effectiveness of surgical treatment and the 
adequacy of chemotherapy administered. 
Immune complex is metabolized chiefly in the 
liver. It was thought that changes in CIC was 
specialized when the liver underwent surgical 
intervension. One of the purpose of this study 
is to clarify the mechanism about changes in 
CIC. On the other hand, TAKAHASHI5) first 
reported the result of the measurement of 
CRA by the use of radioisotope. Recently it 
became clear that CRA can be measured by 
spectrophotometry 6 ). The results by this 
method are not different from those by RI 
method in accuracy. This method was commonly 
used and applied to monitoring collagen and 
infections diseases to assess the effect of
therapy. It is of great use that positive CRA 
is indicative of the presence of malignant 
diseases. There were variable changes in the 
present study of benign diseases with infection, 
such as cholecystitis and pneumonia. Mean-
while, CIC levels changed in regular manner as 
far as gastric cancer was concerned. When the 
cancer lesion was curatively resected, its level 
significantly fell down until the 14th day. On 
the contrary, it remained invariable in patients 
with non-curative operation. In addition, a 
different mode of CIC change was found in 
hepatic surgery as compared with in other 
gastrointestinal surgeries for carcinomas. The 
blood levels of CIC were often suppressed for 
10 days after operation. It seems that surgical 
intervension to the liver contributes to the 
reduction of CIC levels, which is a reflection of 
IC metabolism. 7 ) The generation of IC was 
also inhibited on the condition of surgical 
damage to the liver, although changes in IC 
were free from surgical insult on the 14th day. 
 The alternation of CRA means the comple-
ment activity in alternative pathway. It is 
widely accepted that complement proteins, for 
example C3 or C4, increased according'to the 
development of carcinoma s ). CRA fails to 
indicate the amount of comlement protein. 
CRA reflects an activity of alternative path-
way of complement. The initial reactant of the 
pathway was C3. C3 was produced in the liver. 
Consequently it may cause depression of CRA 
by hepatic surgery. In fact, CRA was deppressed
in evolving hepatoma much more than in other 
malignant diseases. An appearance of CRA in 
blood also correlates with an advance in 
gastric cancer extension. However, study on 
CRA has been sporadically reported. It was 
also clarified in this study that functional 
activity of complement, that is CRA, increased 
according to.advance of the disease stage of 
gastric cancer. On the other hand, CRA in 
hepatoma was deppressed much more than in 
other malignant diseases, It is important to 
contemplate a mechanism about CRA change. 
Since liver function seems to contribute to 
maintain CRA value, CIC and CRA changes 
revealed a specifical pattern in hepatoma. Low 
blood levels and inactivated complements are 
more likely to be indicative of great consump-
tion as reported by TANrucHI-). Based on this 
fact, hepatic surgery results in lowered CIC 
levels so that complement protein may be 
markedly decreased. CRA value was thought 
to be low to consume complement during 7 
days following operation. Application of 
evaluation of CEA, a-Fetoprotein, CA 19-9, 
and other proteins detected by tumor specific 
monoclonal antibody and the their combina-
tion assay have been clinically used for detec-
tion of malignant diseases. It is difficult to 
conclude that CIC is of great benefit to detect 
a presence of malignant diseases and assess in 
the clinical course of the extension of malig-
nant diseases. CIC and CRA changes are 
associated with complement consumption. It is 
of benefit to know coexisting infectious state 
or postoperative complications by evaluating 
these changes. Even though CIC levels were 
within normal or not detected, its change 
might has varied for 7 days after operation. 
On the other hand, it is important to measure 
nutritional index for considering the clinical 
significance of blood level of CRA and CIC. In 
fact, the first reactant of CRA is C 3. In 
addition, it is generated in the liver which is 
the most important metabolic organ. Further-
more, it is clear that CIC is mainly . metaboliz-
ed in the liver. 
 It is expected that the nutritional state is 
influencing on CRA and CIC values through 
the metabolism of the liver. In relation to 
nutritional index in this study, it seems to be
considered that postoperative nutritionnal 
change is not concerned with the opetation 
insults of gastrectomy and hepatectomy. The 
fact would indicate RBP recovery is so delayed 
in patients with hepatic surgery related to the 
liver compared with those with gastrectomy 
that it suggests postoperative changes in CIC 
and CRA is more likely to be influenced by 
liver dysfunction. Needles to say, it must take 
it into consideration that CIC levels are 
directly influenced by factors of operative 
injury, catabolic metabolism, nutritional de-
ficiency and accompanying infection in all the 
cases for about 7 days after operation irrespec-
tive of preoperative CIC levels. 
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